Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL31172741 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL2031104 | 1.00 | MEN1 (0.39) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL4243306 | 1.00 | MEN1 (0.39) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL8580664 | 1.00 | MEN1 (0.39) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL736943 | 0.94 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL5466599 | 0.94 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL65507 | 0.94 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL49535 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL21059468 | 0.94 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL905465 | 0.94 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1352 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122051257-A | Preparation method and application of oxygen reduction electrocatalyst based on natural polyphenol | 天津科技大学 | 2026-05-15 | — | — | CN | claimed |
| CN-119753651-A | Zn-Fe-P chemical plating gradient anti-abrasion layer and preparation method thereof | 国网浙江省电力有限公司电力科学研究院 | 2025-04-04 | — | — | CN | claimed |
| CN-119571300-A | ZnFeP-particle gradient anti-abrasion chemical composite coating and preparation method thereof | 国网浙江省电力有限公司电力科学研究院 | 2025-03-07 | — | — | CN | claimed |
| CN-118146443-A | Foaming porous solid water-soluble polymer and preparation method thereof | 江苏富淼科技股份有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-117949579-B | Method for detecting methoxy stable isotope ratio of biodegradable lignin | 陕西省西安植物园(陕西省植物研究所) | 2024-05-28 | — | — | CN | claimed |
| CN-117602911-B | Saline-alkali-resistant rapid repair mortar and preparation method thereof | 江苏欧西建材科技发展有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-117949579-A | Method for detecting methoxy stable isotope ratio of biodegradable lignin | 陕西省西安植物园(陕西省植物研究所) | 2024-04-30 | — | — | CN | claimed |
| CN-117843282-A | Vertical impermeable material based on modified attapulgite, and preparation and application thereof | 安徽省城建设计研究总院股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117624463-A | Preparation method of hydroxamic acid type polyacrylamide inverse emulsion | 江苏富淼科技股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117602911-A | Saline-alkali-resistant rapid repair mortar and preparation method thereof | 江苏欧西建材科技发展有限公司 | 2024-02-27 | — | — | CN | claimed |
| US-20070004021-A1 | Plating media for the identification of Yersinia pestis | R&F PRODUCTS, INC. | 2007-01-04 | — | — | US | claimed |
| WO-2006102059-A2 | METHOD AND COMPOSITION FOR IMPROVED TEMPORARY WET STRENGTH | KEMIRA OYJ (FI) | 2006-09-28 | — | — | WO | claimed |
| US-6767558-B2 | ADDING TO A PHARMACEUTICAL FORMULATION SUSCEPTIBLE TO OXIDATION, AN OXIDATION-INHIBITING AMOUNT OF A FERROUS ION SOURCE, PREFERABLY IN THE FORM OF AN EXCIPIENT | PFIZER INC. | 2004-07-27 | — | — | US | claimed |
| US-20020183392-A1 | Inhibiting oxidative degradation of pharmaceutical formulations | WANG HAI (US) | 2002-12-05 | — | — | US | claimed |
| US-6423351-B2 | (2S,3S)-N-(5-ISOPROPYL-2-METHOXYPHENYL)METHYL-2-DIPHENYLMETHYL -1-AZABICYCLO(2.2.2.)OCTANE-3-AMINE OR LASOFOXIFEN TARTARATE OXIDATION SUSCEPTIBLE ACTIVE DRUGS AND AN OXIDATION RESISTANCE FERROUS ION SOURCE IN THE FORM OF EXCIPIENT | PFIZER INC. | 2002-07-23 | — | — | US | claimed |
| US-20010047034-A1 | Inhibiting oxidative degradation of pharmaceutical formulations | WANG HAI (US) | 2001-11-29 | — | — | US | claimed |
| EP-1145719-A2 | Use a ferrous salt for inhibiting oxidative degradation of pharmaceutical formulations | Pfizer Products Inc. (US) | 2001-10-17 | — | — | EP | claimed |
| EP-0569334-B1 | Process for preparing N-methoxy derivatives of 4-hydroxy-2,2,6,6-tetramethylpiperidine and 2,2,6,6-tetramethyl-4-piperidone | CIBA GEIGY AG (CH) | 1995-02-15 | — | — | EP | claimed |
| US-5374729-A | Treating N-oxyl hindered amine with hydrogen peroxide and a peroxide-decomposing transition metal salt in the presence of dimethyl sulfoxide | CIBA-GEIGY CORPORATION (US) | 1994-12-20 | — | — | US | claimed |
| EP-0569334-A1 | Process for preparing N-methoxy derivatives of 4-hydroxy-2,2,6,6-tetramethylpiperidine and 2,2,6,6-tetramethyl-4-piperidone | CIBA-GEIGY AG (CH) | 1993-11-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010047034-A1 | Inhibiting oxidative degradation of pharmaceutical formulations | SQOR, HMOX1, PRDX3 | MEN1 3779/4885ALDH1A1 350/4885TSHR 3675/4885 |
| US-20020183392-A1 | Inhibiting oxidative degradation of pharmaceutical formulations | HMOX1, LPO, FECH | MEN1 3900/4885ALDH1A1 366/4885TSHR 4022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.